logo
logo
Sign in

Genitourinary Drugs Market Size To Witness A CAGR Exceeding 1.65% By 2023 | Top Key Companies, Future Insights and Latest Trends

avatar
rahul kumar
Genitourinary Drugs Market Size To Witness A CAGR Exceeding 1.65% By 2023 | Top Key Companies, Future Insights and Latest Trends

Aug 09, 2019 (Heraldkeepers) -- Genitourinary Drugs Marketsize to Exhibit aCAGR of 1.65%over the forecast period 2018 to 2023.

Genitourinary disorders are caused by damage to the urinary tract or genital organs.

The increasing cases of genitourinary disorders, surge in number of people suffering from cancer, increasing prevalence of sexually transmitted diseases, and rise in number of drugs in pipeline are the major factors driving the growth of the global genitourinary drugs market.

According to the Centers for Disease Control and Prevention (CDC), more than 2.3 million Americans were diagnosed with sexually transmitted diseases in year 2017, Most common sexually transmitted diseases in American region are chlamydia, gonorrhea, and syphilis.

Moreover, increase in strategic collaborations and aggressive strategy adopted by major players in the market is also responsible for the growth of the market.

The European market is expected to be the second-largest due to the government initiatives for the development of healthcare sector, increasing research and development activities in the region and rise in number of chronic disorders.

collect
0
avatar
rahul kumar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more